Skip to content

Clinical trials on the effect of lidocaine on sevoflurane-induced delirium or restlessness during the recovery period

Clinical trials on the effect of lidocaine on sevoflurane-induced delirium or restlessness during the recovery period

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125369
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-05-31
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium or restlessness during the recovery period

Interventions

Lidocaine group (Group L):Five minutes before the end of the operation, 1.5mg/kg of lidocaine was intravenously injected
Control Group (Group C):Five minutes before the end of the operation, 1.5mg/kg of normal saline was intravenously injected

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 16 Years

Inclusion criteria

Inclusion criteria: Select patients who are scheduled for elective surgery under general anesthesia, regardless of gender, aged 3 to 16 years, with ASA grade I to II, and the estimated operation time is 30 minutes to 2 hours.

Exclusion criteria

Exclusion criteria: 1. Known lidocaine allergy or contraindications; 2. Arrhythmia, epilepsy, intracranial hypertension; 3. Liver/kidney insufficiency; 4. Mental retardation or inability to cooperate with assessment; 5. Sedative/analgesic drugs used within 48 hours before surgery; 6. Emergency surgery or mechanical ventilation required after surgery; 7. BMI > 95th percentile or < 5th percentile.

Design outcomes

Primary

MeasureTime frame
The PAED score is >= 12 points;Exploration mechanism;

Secondary

MeasureTime frame
Reduce the severity of ED;Promote rapid awakening;Improve the quality of postoperative recovery;Evaluate safety;

Countries

China

Contacts

Public ContactFeng Yan

Affiliated Hospital of North Sichuan Medical College

1017018674@qq.com+86 158 8262 6422

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026